These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25757366)

  • 21. Perimenopause: From Research to Practice.
    Santoro N
    J Womens Health (Larchmt); 2016 Apr; 25(4):332-9. PubMed ID: 26653408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive-behavioral, behavioral, and mindfulness-based therapies for menopausal depression: a review.
    Green SM; Key BL; McCabe RE
    Maturitas; 2015 Jan; 80(1):37-47. PubMed ID: 25458709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on management of genitourinary syndrome of menopause: A practical guide.
    Palacios S; Castelo-Branco C; Currie H; Mijatovic V; Nappi RE; Simon J; Rees M
    Maturitas; 2015 Nov; 82(3):308-13. PubMed ID: 26261035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Local estrogen therapy--clinical implications--2012 update].
    Kokot-Kierepa M; Bartuzi A; Kulik-Rechberger B; Rechberger T
    Ginekol Pol; 2012 Oct; 83(10):772-7. PubMed ID: 23383564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vulvovaginal atrophy: new and upcoming approaches.
    Simon JA
    Menopause; 2009; 16(1):5-7. PubMed ID: 19131842
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of TCM acupuncture on hot flushes among menopausal women (ACUFLASH) study: a study protocol of an ongoing multi-centre randomised controlled clinical trial.
    Borud EK; Alraek T; White A; Fonnebo V; Grimsgaard S
    BMC Complement Altern Med; 2007 Feb; 7():6. PubMed ID: 17324253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Personal opinion: Treatment of vulvovaginal atrophy--are hidden interests and misinformation preventing better management?
    Pines A; Sturdee DW
    Climacteric; 2015; 18(6):802-4. PubMed ID: 26397968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overall Safety of Ospemifene in Postmenopausal Women from Placebo-Controlled Phase 2 and 3 Trials.
    Simon JA; Altomare C; Cort S; Jiang W; Pinkerton JV
    J Womens Health (Larchmt); 2018 Jan; 27(1):14-23. PubMed ID: 29064335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NIH State-of-the-Science Conference Statement on management of menopause-related symptoms.
    NIH Consens State Sci Statements; 2005 Mar 21-23; 22(1):1-38. PubMed ID: 17308548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What's a woman to do?
    Kalb C
    Newsweek; 2002 Jul; 139(4):42-5. PubMed ID: 12149807
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of efficacy and safety of conjugated estrogens/bazedoxifene in a Latin American population.
    Palacios S; Arias L; Lavenberg J; Pan K; Mirkin S; Komm BS
    Climacteric; 2016 Jun; 19(3):261-7. PubMed ID: 26940720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The urogenital system and the menopause.
    Calleja-Agius J; Brincat MP
    Climacteric; 2015; 18 Suppl 1():18-22. PubMed ID: 26366796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Menopause-specific quality of life across varying menopausal populations with conjugated estrogens/bazedoxifene.
    Abraham L; Pinkerton JV; Messig M; Ryan KA; Komm BS; Mirkin S
    Maturitas; 2014 Jul; 78(3):212-8. PubMed ID: 24837362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health characteristics of women beginning postmenopausal hormone therapy: have they changed since the publication of the Women's Health Initiative?
    Fournier A; Fritel X; Panjo H; Zins M; Ringa V
    Menopause; 2014 Jul; 21(7):687-93. PubMed ID: 24378763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
    Vicariotto F; Raichi M
    Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative analysis of lifestyle obese women before menopause and perimenopause period].
    Pachocka LM
    Rocz Panstw Zakl Hig; 2010; 61(4):389-93. PubMed ID: 21446121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ISSWSH position statement.
    ISSWSH/NAMS Consensus Committee
    J Sex Med; 2014 May; 11(5):1109. PubMed ID: 24758338
    [No Abstract]   [Full Text] [Related]  

  • 38. Physical activity and risk of hot flashes among women in midlife.
    Whitcomb BW; Whiteman MK; Langenberg P; Flaws JA; Romani WA
    J Womens Health (Larchmt); 2007; 16(1):124-33. PubMed ID: 17324103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause.
    Wurz GT; Kao CJ; DeGregorio MW
    Clin Interv Aging; 2014; 9():1939-50. PubMed ID: 25419123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 'Feeling hot, hot, hot': is there a role for exercise in the management of vasomotor and other menopausal symptoms?
    Daley AJ; Stokes-Lampard H; MacArthur C
    J Fam Plann Reprod Health Care; 2007 Jul; 33(3):143-5. PubMed ID: 17609065
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.